Indian benchmark indices are expected to open positively on Thursday, July 2, 2026, with Gift Nifty futures trading at 23,166, up 74 points at 7:35 AM, indicating a favourable start amid mixed global cues. However, Asian markets traded mostly lower, with South Korea's Kospi falling 5.36% at the open, prompting the Korea Exchange to impose a five-minute trading halt to curb market volatility. Japan's Nikkei 225 was down 0.70%, while Australia's S&P/ASX 200 declined 0.59%. Overnight in the US, Wall Street's indices finished lower as technology shares fell, with the Dow Jones Industrial Average falling 0.03%, the S&P 500 losing 0.22%, and the Nasdaq Composite declining 0.66%. In commodities, oil prices edged lower with Brent crude falling 1.23% to $70.69 a barrel.
Several stocks are likely to remain in focus on Thursday due to their own positive triggers. Bharti Airtel's Airtel Money, the non-banking financial company (NBFC) arm, has commenced commercial operations as a Type II non-deposit-taking NBFC after receiving a licence from the Reserve Bank of India. CSM Technologies shares are set to make their Dalal Street debut on Thursday after the company raised ₹145.78 crore through its initial public offering (IPO). Lupin announced that the European Medicines Agency (EMA) has approved the expansion of NaMuscla's marketing authorisation, enabling its use in pediatric patients suffering from non-dystrophic myotonic disorders (NDM). Coal India secured a Letter of Award worth ₹2,831.11 crore from Bundelkhand Saur Urja Limited for the development of a 600 MW solar power plant. Medi Assist Healthcare Services completed the acquisition of an additional 31.75% stake in Mayfair through a share transfer from existing shareholders, increasing its shareholding from 60% to 91.75%.
Hero MotoCorp announced the establishment of its second Global Parts Centre (GPC) in Tirupati, Andhra Pradesh, with an investment of over ₹750 crore, taking its cumulative investment commitment in the state to more than ₹3,200 crore. Tata Technologies reported strong Q4 FY2026 results with consolidated net sales of ₹1,572.22 crore, up 22.29% year-on-year, and standalone net sales of ₹829.52 crore, up 8.89% year-on-year. Tata Technologies declared a dividend and reported net profit of ₹204 crore for Q4 FY2026. Tata Technologies and Tenneco LLC have expanded their global partnership for mobility transformation, with Tenneco expected to invest more than $100 million over the next five years. Texmaco Rail & Engineering secured two orders worth a combined ₹351.16 crore, including ₹253.28 crore from JSW (South) Rail Logistics Private Limited and ₹97.88 crore from Sushila Transport Private Limited. Devyani International DMCC and Yellow Palm Co completed additional investments in RD and continue to hold 49% and 51% shareholding, respectively. Syngene International announced that Siddharth Mittal has assumed charge as Managing Director and Chief Executive Officer with effect from July 1, 2026, succeeding Peter Bain. Studds Accessories appointed Bharat Goyal as its Chief Financial Officer and Key Managerial Personnel with effect from July 1, 2026.
Lupin received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey, with a satisfactory Voluntary Action Indicated (VAI) classification. The inspection was conducted between April 13 and April 17, 2026. Brainbees Solutions' board approved participation in the proposed offer for sale (OFS) of equity shares of its subsidiary, Swara Baby, aggregating up to ₹300 crore as part of the subsidiary's proposed initial public offering. NMDC reported robust operational performance during June, with iron ore production increasing 44.3% year-on-year to 5.15 million tonnes and iron ore sales rising 11.2% to 3.98 million tonnes. Coal India announced that its June e-auction allocated 108.76 lakh tonnes of coal and coal products, with prices averaging 42% above the notified price. Sai Parenterals' Australian subsidiary, Noumed Pharmaceuticals, renewed its long-term exclusive OTC Medicines Supply Agreement with one of Australia's leading pharmacy chains, valued at approximately ₹1,300 crore over seven and a half years.
